Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Classificação em ações #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Preço da ação
$0.6
Última sincronização: 2024-08-14
Valor de mercado
$2.09M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
SG
Negociar ASLAN Pharmaceuticals Limited (ASLN)

Categoria

Histórico de preços das ações de ASLAN Pharmaceuticals Limited (ASLN)
Preço de fecho mais alto: $0.60 em 2024-08-01

Preço de fecho mais baixo: $257.66 em 2018-05-01
Histórico de preços das ações da ASLAN Pharmaceuticals Limited de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -84.73%
2023 -78.55%
2022 -63.40%
2021 -35.93%
2020 -19.58%
2019 -41.35%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE